296 related articles for article (PubMed ID: 17497040)
1. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.
Ozbay Y; Akbulut M; Balin M; Kayancicek H; Baydas A; Korkmaz H
Mediators Inflamm; 2007; 2007():89649. PubMed ID: 17497040
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory status in patients with coronary artery ectasia.
Li JJ; Nie SP; Qian XW; Zeng HS; Zhang CY
Cytokine; 2009 Apr; 46(1):61-4. PubMed ID: 19232498
[TBL] [Abstract][Full Text] [Related]
4. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
[TBL] [Abstract][Full Text] [Related]
5. Elevated high sensitivity C-reactive protein and uric acid levels in coronary artery ectasia.
Demir Ş; Karakoyun G; Kanadasi M
Acta Biochim Pol; 2014; 61(4):687-91. PubMed ID: 25285332
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups.
Fan CH; Hao Y; Liu YH; Li XL; Huang ZH; Luo Y; Li RL
BMC Cardiovasc Disord; 2020 Jul; 20(1):330. PubMed ID: 32652935
[TBL] [Abstract][Full Text] [Related]
10. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
Huang W; Chen QW; Lei H; Deng W; Ke DZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
[TBL] [Abstract][Full Text] [Related]
12. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
Piechota W; Piechota W
Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
[TBL] [Abstract][Full Text] [Related]
14. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
[TBL] [Abstract][Full Text] [Related]
16. Independent Prognostic Value of High-sensitivity C-reactive Protein in Patients with Coronary Artery Ectasia.
Wang Y; Wang Y; You S; Wang H; Yin D; Dou K; Song W
Chin Med J (Engl); 2016 Nov; 129(21):2582-2588. PubMed ID: 27779165
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
[TBL] [Abstract][Full Text] [Related]
18. [Changes of plasma high-sensitive C-reactive protein and monocyte chemotactic factor-1 following percutaneous coronary interventional procedures in patients with coronary artery disease].
Wang SL; Han YL; Liu LJ; Yan CH; Kang J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1073-5. PubMed ID: 18583268
[TBL] [Abstract][Full Text] [Related]
19. Comparison of neopterin levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease.
Sahin M; Varol E; Ozaydin M; Altinbas A; Aydin O; Aslan SM; Dogan A; Kaya S
South Med J; 2008 May; 101(5):476-9. PubMed ID: 18414153
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population.
Hrira MY; Kerkeni M; Hamda BK; Chahed H; Ferchichi S; Addad F; Limam HB; Miled A
Cardiovasc Pathol; 2012; 21(6):455-60. PubMed ID: 22425626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
